Towards tailored dialysis fluids in CAPD--the role of reduced calcium and magnesium in dialysis fluids.
Hutchison
A J
AJ
Gokal
R
R
D000536:Aluminum Hydroxide / Q000009:adverse effects* / Q000627:therapeutic use; D002117:Calcitriol / Q000627:therapeutic use; D002118:Calcium / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002119:Calcium Carbonate / Q000627:therapeutic use; D015314:Dialysis Solutions / Q000737:chemistry*; D006801:Humans; D007408:Intestinal Absorption / Q000502:physiology; D008274:Magnesium / Q000008:administration & dosage* / Q000097:blood; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010710:Phosphates / Q000378:metabolism; D010760:Phosphorus Metabolism Disorders / Q000517:prevention & control
D015314:Dialysis Solutions; D010710:Phosphates; D000536:Aluminum Hydroxide; D002117:Calcitriol; D002119:Calcium Carbonate; D008274:Magnesium; D002118:Calcium